Neurocrine Biosciences
NBIX
#1457
Rank
ยฃ9.42 B
Marketcap
ยฃ93.05
Share price
-4.42%
Change (1 day)
6.21%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Earnings for Neurocrine Biosciences (NBIX)

Earnings in 2024 (TTM): ยฃ0.51 Billion

According to Neurocrine Biosciences 's latest financial reports the company's current earnings are ยฃ2.24 Billion. In 2023 the company made an earning of ยฃ0.28 Billion, an increase over its 2022 earnings that were of ยฃ0.17 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Neurocrine Biosciences from 1996 to 2024

Annual earnings

Year Earnings Change
2024 (TTM) ยฃ0.51 B78.9%
2023 ยฃ0.28 B62.85%
2022 ยฃ0.17 B73.74%
2021 ยฃ0.10 B-8.82%
2020 ยฃ0.11 B77.78%
2019 ยฃ62.17 M49.83%
2018 ยฃ41.49 M-142.57%
2017 -ยฃ97.48 Million-14.73%
2016 -ยฃ0.12 Billion53.15%
2015 -ยฃ74.65 Million46.25%
2014 -ยฃ51.04 Million29.66%
2013 -ยฃ39.37 Million-3530.8%
2012 ยฃ1.14 M-95.73%
2011 ยฃ26.87 M
2009 -ยฃ37.79 Million-45.38%
2008 -ยฃ69.18 Million-58.87%
2007 -ยฃ0.17 Billion87.3%
2006 -ยฃ89.79 Million351.97%
2005 -ยฃ19.87 Million-52.09%
2004 -ยฃ41.47 Million-10.98%
2003 -ยฃ46.59 Million
2001 -ยฃ34.78 Million
1999 -ยฃ15.69 Million108.32%
1998 -ยฃ7.53 Million
1996 ยฃ2.29 M

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
ยฃ17 M-96.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.96 B 85.21%๐Ÿ‡ฌ๐Ÿ‡ง UK
-ยฃ24.09 Million-104.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ8.04 B 1,445.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ5.59 B 975.99%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ0.97 Billion-284.56%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ28.13 M-94.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-ยฃ33.1 Million-106.36%๐Ÿ‡บ๐Ÿ‡ธ USA